Mike The Pike Productions, Inc. to Attend American Film Market® ; Launches Discussions with Sales Agents and Buyers on Sci-Fi Thriller ‘White Space’, George R.R. Martin’s ‘The Skin Trade’
LOS ANGELES, CA –-October 27, 2011- Mike the Pike Productions, Inc. (OTC: MIKP) announces today it will be attending American Film Market in Early November to showcase sci-fi thriller, White Space, starring Holt McCallany and its Werewolf Chiller, ‘The Skin Trade’ based on the novella by Game of Thrones creator, George R.R. Martin.
The AFM is the premier global marketplace where Hollywood’s decision-makers and trendsetters all gather under one roof. Unlike a film festival, the AFM is a marketplace where production and distribution deals are closed. In just eight days, more than $800 million in deals will be sealed – on both completed films and those in every stage of development and production.
MTP CEO, Mark B. Newbauer, will attend the event with materials from both projects, meeting with top executives in discussions toward a successful sales deal on ‘White Space’ and key partnerships for ‘GRRM’s The Skin Trade’. T
The team is in initial stages of post-production on White Space, and all are confident that meetings at this point will allow the team to secure interest early in the game, maximizing full potential on sales toward multi-million dollar returns.
MIKP execs are confident that progress made through Q4 this year will lead to exponential growth in 2012. Newbauer states, “Baby steps have us at a point where every move we make is an integral benchmark. Each leading to a higher level of industry position, brand and profitability alongside powerful market growth for our shareholders.”
WANT MORE THAN PRESS? — CHECK OUT MIKP BLOG
Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
The Nuemark Group